Repositrak CEO Randall Fields sells $157,114 in stock

Published 28/01/2025, 22:40
Repositrak CEO Randall Fields sells $157,114 in stock

Randall K. Fields, the Chief Executive Officer of ReposiTrak, Inc. (NASDAQ:TRAK), has sold a portion of his holdings in the company. The sale comes as ReposiTrak maintains strong financial health, with InvestingPro data showing impressive gross profit margins of 83% and a remarkable 69% return over the past year. According to a recent SEC filing, Fields sold a total of 7,500 shares of common stock over two days, with transactions occurring on January 27 and 28. The sales were conducted at a weighted average price range between $20.9471 and $20.9516 per share, amounting to a total value of $157,114.

The transactions were carried out through a Rule 10b5-1 trading plan designed to help Fields meet his charitable commitments. Following these sales, Fields retains ownership of 319,500 shares indirectly through the RK Fields Charitable 2022, LLC.

In other recent news, ReposiTrak reported an 8% increase in total revenue to $5.4 million and a 21% rise in GAAP net income to $1.7 million in the fiscal first quarter of 2025. The company has also formed a strategic partnership with Upshop to enhance food traceability, a move that aligns with FDA’s Food Safety Modernization Act requirements. In other developments, ReposiTrak streamlined its share structure by withdrawing its preferred stock series and held its Annual Meeting of Stockholders, which resulted in the election of four directors and the ratification of Haynie & Company as independent auditors for the fiscal year ending June 2025.

ReposiTrak’s management, led by CEO Randy Fields and CFO John Merrill, anticipates that traceability could contribute up to 50% of recurring revenue within three years. The company is making strategic investments in automation and sales to enhance food traceability services, anticipating a significant revenue boost due to new FDA regulations expected by January 2026. ReposiTrak’s strong financial position is also reflected in its record cash balance of $25.8 million, enabling the redemption of preferred shares and the avoidance of renewing a $10 million line of credit.

These recent developments indicate ReposiTrak’s financial health and strategic direction. The company’s focus on automation and customer experience is expected to drive efficient scaling with minimal staff increases. The dividend has also increased by 10%, reflecting confidence in the company’s financial health and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.